| 01/25 | Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) | PR |
| 01/20 | River Private Wealth announces new round of investment in Novavax, Inc | AQ |
| 01/18 | Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster | PR |
| 01/09 | Novavax Inc : Change in Directors or Principal Officers, Regulation FD Disclosure, Financi.. | AQ |
| 01/09 | Novavax Names John C. Jacobs as New President & Chief Executive Officer | PR |
| 01/09 | Novavax : to Participate in the 41st Annual J.P. Morgan Healthcare Conference | PU |
| 2022 | Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and St.. | PR |
| 2022 | Novavax Inc : Entry into a Material Definitive Agreement, Creation of a Direct Financial O.. | AQ |
| 2022 | Novavax Announces Closing of $175.25 Million Offering of Convertible Senior Notes Due 2.. | PR |
| 2022 | Novavax Inc : Entry into a Material Definitive Agreement, Creation of a Direct Financial O.. | AQ |
| 2022 | Novavax Inc : Entry into a Material Definitive Agreement, Other Events, Financial Statemen.. | AQ |
| 2022 | German Health Authority Expands Recommendation for Use of Novavax COVID-19 Vaccine as a.. | AQ |
| 2022 | Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Offi.. | AQ |
| 2022 | Novavax Announces Pricing of $65 Million Public Offering of Common Stock | PR |
| 2022 | Novavax Announces Pricing of $65 Million Public Offering of Common Stock | AQ |
| 2022 | Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes | AQ |
| 2022 | Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes | PR |
| 2022 | Nordson, AbCellera rise; Warner Bros., Novavax fall | AQ |
| 2022 | Novavax Inc : Regulation FD Disclosure, Other Events (form 8-K) | AQ |
| 2022 | Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes | PR |
| 2022 | Novavax Announces Proposed $125 Million Public Offering of Common Stock | PR |
| 2022 | Novavax : Swiss and French Health Authorities Expand Recommendations for Use of Nuvaxovid .. | PU |
| 2022 | NOVAVAX INC Change in Directors or Principal Officers (form 8-K/A) | AQ |
| 2022 | Novavax Nuvaxovid COVID-19 Vaccine Approved in Canada for Use as a Primary Series in Ad.. | PR |
| 2022 | Novavax to Participate in BofA Securities 2022 Virtual Biotech SMID Cap Conference | AQ |
| 2022 | Novavax to Participate in BofA Securities 2022 Virtual Biotech SMID Cap Conference | PR |
| 2022 | World Health Organization Updates Emergency Use Listing for Novavax Nuvaxovid COVID-19 .. | PR |
| 2022 | Novavax - Termination of COVID-19 Vaccine Purchase Agreement with Gavi | AQ |
| 2022 | Novavax Inc : Termination of a Material Definitive Agreement (form 8-K) | AQ |
| 2022 | Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization in Canada as a Boost.. | AQ |
| 2022 | Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization in Canada as a Boost.. | PR |
| 2022 | Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization in Canada as a Boost.. | AQ |
| 2022 | Novavax to Participate in Jefferies London Healthcare Conference | PR |
| 2022 | Novavax Nuvaxovid COVID-19 Vaccine Authorized in the United Kingdom for Use as a Booste.. | AQ |
| 2022 | Novavax Nuvaxovid™ COVID-19 Vaccine▼ Authorized in the United Kingdom for U.. | PR |
| 2022 | NOVAVAX INC Management's Discussion and Analysis of Financial Condition and Results
of.. | AQ |
| 2022 | Novavax : Q3 Earnings Snapshot | AQ |
| 2022 | Novavax Reports Third Quarter 2022 Financial Results and Operational Highlights | PR |
| 2022 | Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued and Future Use of Novavax.. | PR |
| 2022 | Novavax to Host Conference Call to Discuss Third Quarter 2022 Financial Results and Ope.. | AQ |
| 2022 | Novavax Inc : Change in Directors or Principal Officers, Financial Statements and Exhibits.. | AQ |
| 2022 | Novavax Appoints Rick Rodgers to Board of Directors | PR |
| 2022 | Novavax to Host Conference Call to Discuss Third Quarter 2022 Financial Results and Ope.. | PR |
| 2022 | Novavax Showcases Data from Expanding Vaccine Portfolio at IDWeek 2022 | PR |
| 2022 | US okays Novavax covid vaccine as booster for adults | AQ |
| 2022 | US clears Novavax COVID booster dose | AQ |
| 2022 | US clear Novavax COVID booster dose | AQ |
| 2022 | U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as.. | PR |
| 2022 | Novavax COVID-19-Influenza Combination Vaccine Candidate Induced Antibody and T-Cell Re.. | PR |
| 2022 | Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting an.. | PR |
| 2022 | Novavax and SK bioscience file a Post Approval Change Application in South Korea for Nu.. | AQ |
| 2022 | Switzerland's Federal Office of Public Health Recommends Novavax Nuvaxovid COVID-19 Vac.. | AQ |
| 2022 | Novavax - Stanley Erck Opening Statement European Parliament - COVI Committee Hearing D.. | AQ |
| 2022 | Novavax : and SK bioscience File a Post Approval Change Application in South Korea for Nuv.. | PU |
| 2022 | Novavax : Switzerland's Federal Office of Public Health Recommends Novavax Nuvaxovid&trade.. | PU |
| 2022 | Novavax to Share New Data from Growing Vaccine Portfolio at World Vaccine Congress Euro.. | PR |
| 2022 | Novavax Inc : Entry into a Material Definitive Agreement (form 8-K) | AQ |
| 2022 | Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors | AQ |
| 2022 | Novavax Makes One Million Doses of Nuvaxovid Available for Use in the United Kingdom | AQ |
| 2022 | Novavax Makes One Million Doses of Nuvaxovid™ Available for Use in the United Kin.. | PR |
| 2022 | Novavax : Requests Updated Emergency Use Listing from World Health Organization for Nuvaxo.. | PU |
| 2022 | Novavax Nuvaxovid™ COVID-19 Vaccine Receives Expanded Emergency Use Authorization.. | PR |
| 2022 | Novavax Nuvaxovid™ COVID-19 Vaccine Now Available in Israel for Individuals Aged .. | PR |
| 2022 | Fda Roundup : September 13, 2022 | AQ |
| 2022 | Novavax and Serum Institute of India Announce Full Product Registration in South Africa.. | PR |
| 2022 | Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Conditional Marketing Author.. | PR |
| 2022 | Novavax to Participate in Upcoming September Conferences | PR |
| 2022 | World Health Organization Approves SK bioscience as a Supplier of Novavax Nuvaxovid COV.. | AQ |
| 2022 | Swissmedic Authorizes Novavax Nuvaxovid COVID-19 Vaccine for Adolescents Aged 12 Throug.. | AQ |
| 2022 | Swissmedic Authorizes Novavax Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12.. | PR |
| 2022 | Novavax Nuvaxovid™ COVID-19 Vaccine Recommended by CHMP for Expanded Conditional .. | PR |
| 2022 | Novavax Nuvaxovid COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization.. | AQ |
| 2022 | Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Conditional Marketing Author.. | PR |
| 2022 | Novavax : U.S. Centers for Disease Control and Prevention Expands Recommendation for Novav.. | PU |
| 2022 | U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted fo.. | PR |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
